fda oral semaglutide Approves High-Dose 25mg | Robert Gabbay MD, PhD posted on the topic Novo Nordisk's weight-loss pill wins
Description
Although data on pregnancy outcomes with exposure to these medications is limited, they are not recommended during pregnancy
Looking for GLP-1 support
Although the complete effects of Wellbutrin XL on the developing baby are still being studied it is advised to proceed with caution
The new 7.2 mg dose, available since 2026, will lead to a similar reduction in energy as Mounjaro
The randomized, double-blind, placebo-controlled study tested various doses of Danuglipron against a placebo over 16 weeks
